Markets:

Overview

News

Currencies

International

Treasuries

Design Therapeutics, Inc. - Common Stock (NQ:DSGN)

9.770 -0.050 (-0.51%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Design Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio

November 07, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference

September 10, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio

August 05, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains ↗

May 22, 2024

Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.

Via InvestorPlace

Earnings Preview For Design Therapeutics ↗

March 18, 2024

Via Benzinga

DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024 ↗

May 08, 2024

DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones

May 08, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 07, 2024

Via Benzinga

Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

May 07, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗

March 26, 2024

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023 ↗

March 19, 2024

DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

March 19, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update

March 12, 2024

From Design Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024

November 13, 2023

From Design Therapeutics, Inc.

Via GlobeNewswire

Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

August 31, 2023

The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Topics Stocks

Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch ↗

August 17, 2023

All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week.

Via Benzinga

Topics Stocks

Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments ↗

August 15, 2023

RBC Capital Market downgraded Design Therapeutics Inc (NASDAQ: DSGN) from Outperform to Sector Perform with a price target of $7,

Via Benzinga

Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher ↗

August 15, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The...

Via Benzinga

Topics Stocks

Why Shares of Design Therapeutics Are Plummeting on Tuesday ↗

August 15, 2023

The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.

Via The Motley Fool

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 15, 2023

Via Benzinga

Crude Oil Down 2%; Home Depot Posts Upbeat Earnings ↗

August 15, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Dow Falls Over 200 Points; US Retail Sales Top Expectations ↗

August 15, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 15, 2023

Via Benzinga

Why Is Design Therapeutics Stock Moving Lower Today? ↗

August 15, 2023

Design Therapeutics Inc (NASDAQ: DSGN) reported initial results from the company's Phase 1 multiple-ascending dose (MAD) clinical trial of DT-216 in

Via Benzinga

Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2023

Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 15, 2023

Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.